Save
Siponimod effect on cortical and deep grey matter in patients with secondary progressive multiple sclerosis
ECTRIMS Online Library, Douglas Arnold, 228117
Natalizumab reduced serum levels of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND study
ECTRIMS Online Library, Raj Kapoor, 228118
How does anti-IL-6 receptor monoclonal antibody tocilizumab treatment ameliorate neuromyelitis optica?
ECTRIMS Online Library, Takako Matsuoka, 228133
Cognitive rehabilitation for attention and memory in people with multiple sclerosis: a randomised controlled trial
ECTRIMS Online Library, Roshan das Nair, 228134
Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure
ECTRIMS Online Library, Alessandra Adamo, 228149
Single-cell analysis of intrathecal B cells in multiple sclerosis
ECTRIMS Online Library, Justyna Polak, 228150
Investigating brain plasticity underlying the early stages of functional recovery in MS
ECTRIMS Online Library, Eleonora Patitucci, 228165
GlucoCEST MRI of blood brain barrier disruption in multiple sclerosis – first human experiments and initial results
ECTRIMS Online Library, Xiang Xu, 228166
Disease activity during pregnancy in patients with AQP4-Ab positive, MOG-Ab positive or double negative NMOSD
ECTRIMS Online Library, Cecilia Alves Do Rego, 228826
Care-seeking of patients with multiple sclerosis over 2010-2015 in France: a nationwide study using health administrative data
ECTRIMS Online Library, Jonathan Roux, 228842
Benchmarks of manual dexterity and walking speed in a large, representative patient population
ECTRIMS Online Library, Carl deMoor, 228860
Real-world outcome in multiple sclerosis estimated from two cost of illness studies and MS clinic data in the Czech Republic
ECTRIMS Online Library, Gisela Kobelt, 228876
Increased risk of infections in patients diagnosed with multiple sclerosis (MS): a study in the UK Clinical Practice Research Database (CPRD)
ECTRIMS Online Library, Susan Jick, 228892
In vivo modeling of the nascent multiple sclerosis lesion: Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires the myelin and lymphocyte protein
ECTRIMS Online Library, Jennifer Linden, 228908
Mechanisms of dysfunction of regulatory B cell activity in multiple sclerosis
ECTRIMS Online Library, Maria Teresa Cencioni, 228924
Understanding memory impairment in multiple sclerosis - contributions of macro and micro-structural alterations in the thalamus and hippocampus
ECTRIMS Online Library, Emma Devenney, 228940
Serum neurofilament light chain correlates with cortical lesion load at 3T and 7T in early RRMS patients
ECTRIMS Online Library, Po-Jui Lu, 228956
Choroid plexus change in neuromyelitis optica spectrum disorder
ECTRIMS Online Library, Hyunjin Kim, 228972
Instrumental, clinical, and patient reported sensorimotor correlates of spinal cord grey and total cord areas
ECTRIMS Online Library, Amber M. Alexander, 228988
Employment status in individuals with multiple sclerosis: Which predictors are important in different disease subtypes?
ECTRIMS Online Library, Alina Renner, 229004
Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
ECTRIMS Online Library, Lidia Stork, 229020
Incidence of confirmed macular oedema in the phase 3 program of ozanimod in relapsing multiple sclerosis
ECTRIMS Online Library, Steven A. Gross, 229036
Switching treatments in progressive MS: how are U.S. neurologists approaching disease-modifying treatment over time?
ECTRIMS Online Library, Robert Naismith, 229052
Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
ECTRIMS Online Library, Stephen L Hauser, 229069
Effect of extended dosing of natalizumab on VLA-4 saturation
ECTRIMS Online Library, Roy Johanson, 229084
MS-PML.org, an e-learning resource for physicians to facilitate early recognition of progressive multifocal leukoencephalopathy in the setting of MS: analysis and interpretation of usage data
ECTRIMS Online Library, Frederik Barkhof, 229085
Dimethyl fumarate-induced lymphocyte drop at six months predicts short-term disease activity in multiple sclerosis: an independent, prospective, post-marketing evaluation
ECTRIMS Online Library, Carla Tortorella, 229100
Treatment effects of fampridine on ambulation and upper extremity function in patients with multiple sclerosis from a real-world evidence cohort
ECTRIMS Online Library, Caspar E.P. van Munster, 229101
Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a case report
ECTRIMS Online Library, Julia Feige, 229116
Action observation training modulates dynamic functional connectivity in patients with multiple sclerosis
ECTRIMS Online Library, Claudio Cordani, 229117
Comparative efficacy of teriflunomide versus dimethyl-fumarate on clinical and MRI outcomes: a two years French multicenter observational study
ECTRIMS Online Library, David Laplaud, 231975
Comparative effectiveness of teriflunomide and dimethyl fumarate in relapsing remitting multiple sclerosis. A Danish nationwide cohort study
ECTRIMS Online Library, Mathias Buron, 231976
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients
ECTRIMS Online Library, Lucia Moiola, 231977
Final results of a placebo controlled, Phase 2 multicenter study of ublituximab (UTX), a novel glycoengineered anti-CD20 monoclonal antibody (mAb), in patients with relapsing forms of multiple sclerosis (RMS)
ECTRIMS Online Library, Edward Fox, 231978
The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis
ECTRIMS Online Library, Joyutpal Das, 231979
Leptomeningeal enhancement in the brain on 7T MRI scans is common and is associated with cortical lesions in relapsing-remitting multiple sclerosis
ECTRIMS Online Library, Jonathan Zurawski, 231980
Quantification of spinal cord atrophy in MS: which software, which vertebral level, spinal cord or brain MRI? A multi-centric, longitudinal comparison of three different volumetric approaches
ECTRIMS Online Library, Carsten Lukas, 231981
Advocacy for surrogacy: magnetisation transfer ratio indicates cortical multiple sclerosis lesion load in vivo
ECTRIMS Online Library, Niraj Mistry, 231982
Detection of multiple sclerosis in brain MRIs using 3D convolutional networks
ECTRIMS Online Library, Kerstin Ritter, 231983
Occurrence of non-linear brain volume loss trajectories in multiple sclerosis patients
ECTRIMS Online Library, Tomas Uher, 231984
Deep immune-profiling of monozygotic twins discordant for multiple sclerosis indicates that genetic identity overrides disease-specific immune features
ECTRIMS Online Library, Lisa Ann Gerdes, 231985
High-dimensional profiling of single memory CD8+T cells reveals a specific pattern in multiple sclerosis patients
ECTRIMS Online Library, Emilie Dugast, 231986
Increased acute axonal injury and elevated oligodendroglial numbers in spinal normal-appearing white matter in MS as compared to neuromyelitis optica
ECTRIMS Online Library, Christiane Wegner, 231987
Substantial 'subependymal-in' gradient of thalamic damage in progressive multiple sclerosis
ECTRIMS Online Library, Roberta Magliozzi, 231988
T-bet-expressing B cells as key drivers of multiple sclerosis: from peripheral induction to local recruitment
ECTRIMS Online Library, Marvin M. van Luijn, 231989
Clinician's view (Europe)
ECTRIMS Online Library, Eva Kubala Havrdová, 231990
Follow-on products for treatment of multiple sclerosis in Latin America: an update
ECTRIMS Online Library, Jorge Correale, 231991
MS society´s view
ECTRIMS Online Library, Michelle Mitchell, 231992
Case 1: The features of anti-MOG antibody-associated CNS demyelination: NMOSD, MS or a novel disease entity?
ECTRIMS Online Library, Martin Weber, 231993
Two cases of anti-MOG associated CNS demyelinating disease
ECTRIMS Online Library, Tobias Derfuss, 231994
When to stop immunotherapy?
ECTRIMS Online Library, John Corboy, 231952
The optimal time to start treatment in relapsing remitting multiple sclerosis patients: results from the Big Multiple Sclerosis Data Network
ECTRIMS Online Library, Pietro Iaffaldano, 231953
Plasma neurofilament light levels segregate treatment effects: results from the IMSE studies with multiple disease modulatory drugs
ECTRIMS Online Library, Bénédicte Delcoigne, 231954
Recurrence of disease activity after fingolimod discontinuation - observations in a real-world cohort with 433 multiple sclerosis patients
ECTRIMS Online Library, Nuria Cerda, 231955
Disease activity during pregnancy after fingolimod withdrawal due to planning a pregnancy in women with multiple sclerosis
ECTRIMS Online Library, Spalmai Hemat, 231956
Update on pathogenesis
ECTRIMS Online Library, Monika Bradl, 231957
Update on therapy
ECTRIMS Online Library, Tania Kümpfel, 231958
The Hungarian population-based prevalence and incidence study of neuromyelitis optica spectrum disorder
ECTRIMS Online Library, Viktoria Papp, 231959
Predictors of outcome after a first attack of Neuromyelitis Optica
ECTRIMS Online Library, Maxime Guillaume, 231960
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study
ECTRIMS Online Library, Frederike C. Oertel, 231961
Serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) in neuromyelitis optica spectrum disorders
ECTRIMS Online Library, Mitsuru Watanabe, 231962
Targeting glia as a strategy to prevent neurodegeneration in MS
ECTRIMS Online Library, Charles ffrench-Constant, 231964
Structural and functional alterations of pyramidal neurons in a model of cortical multiple sclerosis
ECTRIMS Online Library, Adrian-Minh Schumacher, 231965
Nimodipine reduces acute relapse and prevents demyelination in models of multiple sclerosis
ECTRIMS Online Library, Kenneth Smith, 231966
Microglial interaction with nodes of Ranvier: a role in repair?
ECTRIMS Online Library, Thomas Roux, 231967
Selective reduction of AMPA receptors on mature oligodendrocytes prevents demyelination and axonal injury in experimental autoimmune encephalomyelitis
ECTRIMS Online Library, Kirsten Evonuk, 231968
MRI and the diagnosis of MS: from MAGNIMS 2016 to the 2017 revision of the McDonald criteria
ECTRIMS Online Library, Massimo Filippi, 231969
Application of MRI diagnostic criteria in clinical practice
ECTRIMS Online Library, Mar Tintore, 231970
MRI and multiple sclerosis misdiagnosis and differential diagnosis
ECTRIMS Online Library, Frederik Barkhof, 231971
Overview
ECTRIMS Online Library, Vincent de Groot, 231972
Exercise for gait therapy
ECTRIMS Online Library, Peter Feys, 231973
Pharmacological and non-pharmacological treatment of fatigue
ECTRIMS Online Library, Vincent de Groot, 231974
Accuracy versus reproducibility: comprehensive assessment of four automated methods for multiple sclerosis lesion segmentation
ECTRIMS Online Library, Mário João Fartaria, 229576
Evolving MS treatment with immune reconstitution therapy
ECTRIMS Online Library, Gavin Giovannoni, 231941
Committing to patients, impacting individuals: towards an individualised approach for patients with MS
ECTRIMS Online Library, Session Speakers, 234394
Immunological rationale
ECTRIMS Online Library, Paolo A. Muraro, 231926
Immune reconstitution therapy: pressing the reset button
ECTRIMS Online Library, Gavin Giovannoni, 231927
Escalation therapy: staying on the safe side
ECTRIMS Online Library, Daniel Ontaneda, 231928
Longitudinal fMRI
ECTRIMS Online Library, Maria Assunta Rocca, 231929
MRI-pathological correlation
ECTRIMS Online Library, Jeroen Geurts, 231930
Advanced imaging of neurodegeneration
ECTRIMS Online Library, Frederik Barkhof, 231931
Affinity proteomics for array based profiling of autoantibody repertoires
ECTRIMS Online Library, Peter Nilsson, 231932
High-dimensional cytometry for immunophenotyping
ECTRIMS Online Library, Burkhard Becher, 231933
Depression and fatigue: how to break the vicious circle
ECTRIMS Online Library, Anthony Feinstein, 231936
Grand perspective on tackling motor impairment
ECTRIMS Online Library, Alan J. Thompson, 231937
What’s in a name? Paediatric MS or another diagnosis?
ECTRIMS Online Library, Tanuja Chitnis, 231938
Treatment of highly active paediatric MS and potential treatment failures
ECTRIMS Online Library, Jutta Gärtner, 231939
The Barcelona cohort
ECTRIMS Online Library, Mar Tintore, 231903
Early cortical pathology and early relapses predict the risk of developing secondary progressive MS
ECTRIMS Online Library, Antonio Scalfari, 231904
Scoring the 10-year risk of ambulatory disability in DMD-treated multiple sclerosis patients: the RoAD score
ECTRIMS Online Library, Claudio Gasperini, 231905
Early MRI predictors of long-term multiple sclerosis outcomes: a 30-year follow-up study of people presenting with clinically isolated syndromes
ECTRIMS Online Library, Karen Chung, 231906
Serum neurofilament light (NfL) for disease prognosis and treatment monitoring in multiple sclerosis patients: is it ready for implementation into clinical care?
ECTRIMS Online Library, Peter Calabresi, 231907
Emerging risk factors: what is the evidence?
ECTRIMS Online Library, Ralf A. Linker, 231915
Molecular mimicry between the autoantigen Anoctamin 2 and Epstein Barr virus nuclear antigen 1 associates with increased risk for multiple sclerosis
ECTRIMS Online Library, Tomas Olsson, 231916
Multiple sclerosis among first- and second-generation immigrants in Denmark. A population-based cohort study.
ECTRIMS Online Library, Nete Munk Nielsen, 231917
Higher body mass index, but not vitamin D status, is associated with greater subsequent loss of brain gray matter volume in multiple sclerosis
ECTRIMS Online Library, Ellen Mowry, 231918
Predicting the course of CIS patients adding modifiable environmental factors such as smoking and vitamin D
ECTRIMS Online Library, Susana Otero, 231919
The white matter lesion in MS
ECTRIMS Online Library, Wolfgang Brück, 231920
The grey matter lesion in multiple sclerosis
ECTRIMS Online Library, Claudia Lucchinetti, 231921
Immunopathogenesis in CNS autoimmunity: lessons from animal models
ECTRIMS Online Library, Alexander Flügel, 231923

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings